Advanced Biomed Inc ADVB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.09
- Day Range
- $5.08–5.20
- 52-Week Range
- $3.61–16.13
- Bid/Ask
- $4.35 / $5.29
- Shares Outstanding
- 1.65M
- Market Cap
- $8.59M
- Volume/Avg
- 3,107 / 123,737
Key Statistics
- Price/Earnings (Normalized)
- 1.12
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 31
- Website
- http://www.advanbiomed.com
Valuation
|
Metric
|
ADVB
|
|---|---|
Price/Earnings (Normalized) | 1.12 |
Price/Book Value | 0.78 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
ADVB
Financial Strength
|
Metric
|
ADVB
|
|---|---|
Quick Ratio | 6.02 |
Current Ratio | 7.38 |
Interest Coverage | — |
Quick Ratio
ADVB
Profitability
|
Metric
|
ADVB
|
|---|---|
Return on Assets (Normalized) | −30.43% |
Return on Equity (Normalized) | −44.18% |
Return on Invested Capital (Normalized) | −44.04% |
Return on Assets
ADVB
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|BSFKq$yl | LOCK|!b& | $199B | |||
| Danaher Corp
DHR
| LOCK|C?q$tLC | LOCK|&W | $142B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|!G%!Ghv< | LOCK|&sB | $44B | |||
| Agilent Technologies Inc
A
| LOCK|yww$!&P | LOCK|$^P | $38B | |||
| Waters Corp
WAT
| LOCK|tyY>Qkk | LOCK|jgb | $37B | |||
| IQVIA Holdings Inc
IQV
| LOCK|d?%@vK$ | LOCK|$BgB% | $35B | |||
| Illumina Inc
ILMN
| LOCK|G^x$VTS | LOCK|khW! | $28B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|^mLkpjx | LOCK|NshG | $27B | |||
| Quest Diagnostics Inc
DGX
| LOCK|s$jv#dx | LOCK|$gRxB | $22B | |||
| Labcorp Holdings Inc
LH
| LOCK|<X#$SG%L | LOCK|NfcGT | $22B |
United States